Ubs Group Ag Stereotaxis, Inc. Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
A detailed history of Ubs Group Ag transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 35,736 shares of STXS stock, worth $76,117. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,736
Previous 41,147
13.15%
Holding current value
$76,117
Previous $93,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding STXS
# of Institutions
97Shares Held
40.9MCall Options Held
70.8KPut Options Held
41.9K-
Dafna Capital Management LLC Los Angeles, CA13.7MShares$29.1 Million7.27% of portfolio
-
Lagoda Investment Management, L.P. New York, NY4.38MShares$9.33 Million4.91% of portfolio
-
Black Rock Inc. New York, NY3.54MShares$7.55 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.53MShares$7.53 Million0.0% of portfolio
-
Arbiter Partners Capital Management LLC New York, NY2.85MShares$6.08 Million5.31% of portfolio
About Stereotaxis, Inc.
- Ticker STXS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,790,096
- Market Cap $159M
- Description
- Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...